📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Qiagen

1.1 - Company Overview

Qiagen Logo

Qiagen

Headquarter: The Netherlands
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of technologies and products for preanalytical sample preparation and linked molecular assay solutions. Supplies diagnostic kits, tests, and assays for human and veterinary molecular diagnostics, with sample and assay consumables offered in kit form. Portfolio includes automated nucleic acid purification systems, sample disruption tools, real-time and digital PCR platforms, and automated PCR setup.

Products and services

  • QIAcuity Digital PCR System: A multiplex-capable system delivering precise, multiplexed quantification for mutation detection, CNV, gene expression, and gene-editing analysis, supporting exact measurements in linked molecular assays
  • Rotor-Gene Q: A precision-engineered real-time PCR cycler with optimized design features enabling reliable analysis and consistent amplification performance for quantitative assays in molecular diagnostics workflows
  • QIAcube HT: An industrial-grade automated system for high-throughput nucleic acid purification in 96-well format, featuring dedicated protocols and accessories to streamline sample preparation across large batches

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Qiagen

Nutcracker Therapeutics Logo

Nutcracker Therapeutics

HQ: United States Website
  • Description: Provider of mRNA therapeutics and an integrated RNA manufacturing platform: the Nutcracker Manufacturing Unit (NMU) for rapid mRNA production from DNA sequences; GMP-in-a-box to lower costs and cycle times; CodonCracker software to optimize RNA sequences; Nutshell delivery vehicles; an RNA therapeutics pipeline across HPV-driven tumors, T cell lymphoma, and genitourinary tumors; and strategic collaborations.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Nutcracker Therapeutics company profile →
SoftGenetics Logo

SoftGenetics

HQ: United States Website
  • Description: Provider of genetic analysis software for researchers and clinicians, including Mutation Surveyor for Sanger DNA variant detection with custom reporting and user management; NextGENe for NGS SNP/indel, structural variant and transcriptome analysis; Geneticist Assistant for NGS variant interpretation, tracking and coverage confirmation; GeneMarker/HTS/MTP for genotyping, forensic NGS and multiple template processing, compatible with major sequencing systems.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full SoftGenetics company profile →
MeiraGTx Logo

MeiraGTx

HQ: United States Website
  • Description: Provider of AAV-based gene therapies for inherited and acquired disorders, including programs for X-linked retinitis pigmentosa (RPGR), RPE65-associated retinal dystrophy, achromatopsia (CNGB3 and CNGA3), radiation-induced xerostomia (AAV2-hAQP1), and Parkinson’s disease (AAV-GAD).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full MeiraGTx company profile →
NeoPhore Logo

NeoPhore

HQ: United Kingdom Website
  • Description: Provider of novel small molecule cancer therapies that stimulate the immune system by targeting DNA mismatch repair to induce neoantigen expression and increase immunogenicity in solid tumors, including PMS2 and MLH1 modulators that convert immune-cold tumors to hot and enhance sensitivity to immune checkpoint inhibitors, plus continuous neoantigen creation and research and development on next-generation targets.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NeoPhore company profile →
Nightingale Health Logo

Nightingale Health

HQ: Finland Website
  • Description: Provider of pioneering blood-testing services and proprietary blood analysis technology that delivers deep health insights, identifies disease risks from a single sample, and measures the effects of lifestyle interventions. Offers Nightingale Pro data platform for detecting population-level disease risks and preventative health needs, and biomarker analysis services for researchers across blood, urine, and dried blood spot samples.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Nightingale Health company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Qiagen

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Qiagen

2.2 - Growth funds investing in similar companies to Qiagen

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Qiagen

4.2 - Public trading comparable groups for Qiagen

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Qiagen

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Qiagen

What does Qiagen do?

Qiagen is a provider of technologies and products for preanalytical sample preparation and linked molecular assay solutions. Supplies diagnostic kits, tests, and assays for human and veterinary molecular diagnostics, with sample and assay consumables offered in kit form. Portfolio includes automated nucleic acid purification systems, sample disruption tools, real-time and digital PCR platforms, and automated PCR setup.

Who are Qiagen's competitors?

Qiagen's competitors and similar companies include Nutcracker Therapeutics, SoftGenetics, MeiraGTx, NeoPhore, and Nightingale Health.

Where is Qiagen headquartered?

Qiagen is headquartered in The Netherlands.

How many employees does Qiagen have?

Qiagen has 1,000 employees 🔒.

When was Qiagen founded?

Qiagen was founded in 2010 🔒.

What sector and industry vertical is Qiagen in?

Qiagen is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Qiagen

Who are the top strategic acquirers in Qiagen's sector and industry

Top strategic M&A buyers and acquirers in Qiagen's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Qiagen?

Top strategic M&A buyers groups and sectors for Qiagen include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Qiagen's sector and industry vertical

Which are the top PE firms investing in Qiagen's sector and industry vertical?

Top PE firms investing in Qiagen's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Qiagen's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Qiagen's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Qiagen's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Qiagen include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Qiagen's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Qiagen?

The key public trading comparables and valuation benchmarks for Qiagen include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Qiagen for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Qiagen with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Qiagen's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Qiagen with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Qiagen's' sector and industry vertical?

Access recent funding rounds and capital raises in Qiagen's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Qiagen